Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001209191-24-000780 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-04 | 2024-01-02 | PCVX | Wassil Jim | COO | S - Sale+OE | $63.91 | -3,000 | 177.6K | -2% | -$191.7K |
| D | 2024-01-04 | 2024-01-02 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 178.9K | +2% | +$7,260 |
| D | 2024-01-04 | 2024-01-02 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -3,000 | 93.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 110 | $65.15 | 175,935 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-02 | S | D | 1,562 | $64.29 | 176,045 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $64.13 to $64.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-01-02 | S | D | 289 | $62.71 | 178,646 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-01-02 | M | A | 3,000 | $2.42 | 178,935 | D | — | — | |
| 5 | Common | Common Stock | 2024-01-02 | S | D | 1,039 | $63.55 | 177,607 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $63.13 to $63.885. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2024-01-02 | M | D | 3,000 | $0.00 | 93,555 | D | $2.42 · — to 2029-12-16 | 3,000 Common Stock | (F5) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter. |